Is liver SUV stable over time in 18F-FDG PET imaging?

Journal of Nuclear Medicine Technology

Volumn 39, Issue 4, 2011, Pages 258-263

  Laffon, Eric ^a,c   Adhoute, Xavier ^a,b   de Clermont, Henri ^a,b   Marthan, Roger ^a,c  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

Author keywords

Injection acquisition time delay; Kinetic model analysis; Liver physiology; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIVER FUNCTION; LIVER METABOLISM; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; STANDARDIZED UPTAKE VALUE;

ADULT; AGED; AGED, 80 AND OVER; COMPUTER SIMULATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84855609834     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.111.090027     Document Type: Article

References (22)

1. Huang SC. Anatomy of SUV. Nucl Med Biol. 2000;27:643-646.
2. 18F-FDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45:784-788.
3. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(suppl):122S-150S.
4. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(suppl):11S-20S.
5. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of 18FDG. J Nucl Med. 1978;19:1154-1161.
6. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
7. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2- fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-388.
8. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
9. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab. 1985;5:584-590.
10. Hunter GJ, Hamberg LM, Alpert NM, Choi NC, Fischman AJ. Simplified measurement of deoxyglucose utilization rate. J Nucl Med. 1996;37:950-955.
11. 18F-FDG uptake: a dynamic approach. J Nucl Med. 2004;45:1328-1333.
12. 18FDG uptake in the normal liver using dynamic PET: impact and modelling of the dual hepatic blood supply. J Nucl Med. 2001;42:1265-1273.
13. Munk OL, Bass L, Roelsgaard K, Bender D, Hansen SB, Keiding S. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. J Nucl Med. 2001;42:795-801.
14. Iozzo P, Jarvisalo MJ, Kiss J, et al. Quantification of liver glucose metabolism by positron emission tomography: validation in pigs. Gastroenterology. 2007;132: 531-542.
15. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med. 1992;33:333-339.
16. Cui Y, Bai J. Comparison of parameter estimations using dual-input and arterialinput in liver kinetic studies of FDG metabolism. Conf Proc IEEE Eng Med Biol Soc. 2005;3:2345-2348.
17. Vriens D, de Geus-Oei L-F, Oyen WJG, Visser EP. A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment. J Nucl Med. 2009;50:1933-1939.
18. 18F]FDG lung metabolism with late dynamic PET imaging. Mol Imaging Biol. 2011;13:378-384.
19. Messa C, Choi Y, Hoh CK, et al. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr. 1992;16:684-689.
20. Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med. 2001;28:696-703.
21. Munk OL, Keiding S. Quantification of 18FDG uptake in the liver using dynamic PET. J Nucl Med. 2002;43:439-441.
22. Blustajn J, Cuenod CA, Clement O, Siauve N, Vuillemin-Bodaghi V, Frija G. Measurement of liver blood volume using a macromolecular MRI contrast agent at equilibrium. Magn Reson Imaging. 1997;15:415-421.